A novel nucleic acid sensing-related genes signature for predicting immunotherapy efficacy and prognosis of lung adenocarcinoma

CONCLUSION: We found a significant correlation between nucleic acid sensing function and the immune treatment efficiency in LUAD. The NASRS can be used as a robust biomarker for the predicting of prognosis and immunotherapy efficiency and may help in clinical decisions for LUAD patients.PMID:37592781 | DOI:10.2174/1568009623666230817101843

Source: Current Cancer Drug Targets - August 18, 2023 Category: Cancer & Oncology Authors: Xinhao Peng Hong Wu Biqin Zhang Chuan Xu Jinyi Lang Source Type: research